Displaying 151 - 166 of 166 results
Released Company Title Industry Topic
02 Nov 2023
21:01 CET
GALAPAGOS Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023 20103010 Biotechnology Other subject
02 Nov 2023
21:01 CET
GALAPAGOS Galapagos rapporteert derde kwartaal 2023 resultaten en deelt nieuwe bemoedigende data van CAR-T studies die op ASH 2023 gepresenteerd worden 20103010 Biotechnology Other subject
30 Oct 2023
21:01 CET
GALAPAGOS Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma 20103010 Biotechnology Other subject
30 Oct 2023
21:01 CET
GALAPAGOS Galapagos rondt strategische oefening af en ondertekent intentieverklaring om Jyseleca®-activiteiten over te dragen aan Alfasigma 20103010 Biotechnology Other subject
19 Sep 2023
22:01 CEST
GALAPAGOS Galapagos appoints Simon Sturge to its Board of Directors 20103010 Biotechnology Other subject
19 Sep 2023
22:01 CEST
GALAPAGOS Galapagos benoemt Simon Sturge tot lid van haar Raad van Bestuur 20103010 Biotechnology Other subject
28 Aug 2023
22:01 CEST
GALAPAGOS Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus   20103010 Biotechnology Other subject
28 Aug 2023
22:01 CEST
GALAPAGOS Galapagos kondigt de start aan van een fase 2-studie met de selectieve TYK2-remmer GLPG3667 bij patiënten met actieve systemische lupus erythematodes   20103010 Biotechnology Other subject
03 Aug 2023
22:01 CEST
GALAPAGOS Galapagos announces first half-year 2023 financial results 20103010 Biotechnology Other subject
03 Aug 2023
22:01 CEST
GALAPAGOS Galapagos rapporteert financiële resultaten over het eerste halfjaar van 2023 20103010 Biotechnology Other subject
15 Jun 2023
22:01 CEST
GALAPAGOS Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer 20103010 Biotechnology Other subject
15 Jun 2023
22:01 CEST
GALAPAGOS Galapagos benoemt Thad Huston tot Chief Financial Officer en Chief Operating Officer 20103010 Biotechnology Other subject
12 Jun 2023
22:01 CEST
GALAPAGOS Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board 20103010 Biotechnology Other subject
12 Jun 2023
22:01 CEST
GALAPAGOS Galapagos benoemt Dr. Susanne Schaffert tot niet-uitvoerend onafhankelijk lid van de Raad van Bestuur 20103010 Biotechnology Other subject
05 Jun 2023
22:01 CEST
GALAPAGOS Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress 20103010 Biotechnology Other subject
05 Jun 2023
22:01 CEST
GALAPAGOS Galapagos toont CAR-T point-of-care productie en eerste fase 1/2 CLL-data met CD19 CAR-T kandidaat, GLPG5201, op het EHA 2023 congres 20103010 Biotechnology Other subject